QSAM — Qsam Biosciences Balance Sheet
0.000.00%
- $35.56m
- $34.18m
Annual balance sheet for Qsam Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0 | 0.008 | 1.5 | 0.225 | 1.39 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.008 | 0.021 | 1.67 | 0.365 | 1.71 |
| Net Property, Plant And Equipment | 0 | — | — | — | — |
| Total Assets | 0.008 | 0.021 | 1.67 | 0.365 | 1.71 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.8 | 4.19 | 1.39 | 1.58 | 1.03 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 3.83 | 4.3 | 1.39 | 1.58 | 1.03 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -3.82 | -4.28 | 0.277 | -1.22 | 0.672 |
| Total Liabilities & Shareholders' Equity | 0.008 | 0.021 | 1.67 | 0.365 | 1.71 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |